Vera Therapeutics, Inc. Class A Common Stock (VERA) is a publicly traded Healthcare sector company. As of August 9, 2026, VERA trades at $32.99 with a market cap of $2.30B and a P/E ratio of -6.94. VERA moved +2.73% today. Year to date, VERA is -32.35%; over the trailing twelve months it is +66.78%. Its 52-week range spans $18.53 to $56.05. Analyst consensus is strong buy with an average price target of $82.08. Rallies surfaces VERA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Vera Therapeutics, Inc. Class A Common Stock (VERA) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. VERA moved +2.73% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $32.99 |
| Market Cap | $2.30B |
| P/E Ratio | -6.94 |
| EPS | $-4.66 |
| Dividend Yield | 0.00% |
| 52-Week High | $56.05 |
| 52-Week Low | $18.53 |
| Volume | 1.24M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-299.62M |
| Gross Margin | 0.00% |
14 analysts cover VERA: 0 strong buy, 13 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $82.08.